-
PROVIDERS
Read more
Browse our latest selection of abstracts, manuscripts, and presentations.
-
LIFE SCIENCES
LIVE WEBINAR
Optimizing research with RWD: How Lens accelerates time to insights in drug discovery.
Register now. -
PATIENTS
It's About Time
View the Tempus vision.
- RESOURCES
-
ABOUT US
View Job Postings
We’re looking for people who can change the world.
06/03/2023
Industry Expert Theater Presentation* from the 2023 ASCO® Annual Meeting
AI-Enabled Precision Medicine is Here: Leveraging insights derived from data to advance cancer care
Authors
Ezra Cohen, MD
Chief Medical Officer of Oncology, Tempus
Kate Sasser, PhD
Chief Scientific Officer, Tempus
Calvin Chao, MD
Senior Vice President of Medical Affairs, Tempus
Chief Medical Officer of Oncology, Tempus
Kate Sasser, PhD
Chief Scientific Officer, Tempus
Calvin Chao, MD
Senior Vice President of Medical Affairs, Tempus
Hear from Drs. Ezra Cohen, Kate Sasser and Calvin Chao from Tempus as they explore the intersection of real world data, machine learning, and genomic sequencing to revolutionize patient care. They discuss Tempus’ suite of technologies and NGS platform which work together to rapidly deliver insights that are transforming precision oncology from clinical development to the oncology practice.
*Not an official event of the 2023 ASCO® Annual Meeting. Not sponsored, endorsed, or accredited by ASCO®, CancerLinQ®, or Conquer Cancer® the ASCO Foundation. Not CME accredited.
-
04/15/2024Identifying patients with Valvular Heart Disease: A partnership between a specialty designated cardiac center and Tempus
Learn how the deployment of Tempus Next, an AI-enabled clinical care pathway solution, at a specialty designated cardiac and heart valve center helped enable guideline directed care for patients with structural heart disease.
Read more -
04/15/2024Closing the biomarker testing gap for early stage NSCLC patients with Tempus Next
Learn how Tempus Next was deployed at TriHealth Cancer and Blood Institute in Cincinnati, Ohio to surface and close gaps in biomarker testing for NSCLC patients.
Read more -
11/15/2023Personalized depression treatment with pharmacogenomic testing
This real-world case shows the impact of using the Tempus nP PGx report to inform treatment in major depressive disorder (MDD).
Read more